Korsakov M - Search Results

1

1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer.

Shetnev A, Baykov S, Kalinin S, Belova A, Sharoyko V, Rozhkov A, Zelenkov L, Tarasenko M, Sadykov E, Korsakov M, Krasavin M. Shetnev A, et al. Among authors: korsakov m. Int J Mol Sci. 2019 Apr 5;20(7):1699. doi: 10.3390/ijms20071699. Int J Mol Sci. 2019. PMID: 30959765 Free PMC article.

2

Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.

Krasavin M, Korsakov M, Dorogov M, Tuccinardi T, Dedeoglu N, Supuran CT. Krasavin M, et al. Among authors: korsakov m. Eur J Med Chem. 2015 Aug 28;101:334-47. doi: 10.1016/j.ejmech.2015.06.022. Epub 2015 Jun 25. Eur J Med Chem. 2015. PMID: 26160114

3

Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds.

Krasavin M, Korsakov M, Zvonaryova Z, Semyonychev E, Tuccinardi T, Kalinin S, Tanç M, Supuran CT. Krasavin M, et al. Among authors: korsakov m. Bioorg Med Chem. 2017 Mar 15;25(6):1914-1925. doi: 10.1016/j.bmc.2017.02.018. Epub 2017 Feb 13. Bioorg Med Chem. 2017. PMID: 28237553

4

Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases.

Krasavin M, Korsakov M, Ronzhina O, Tuccinardi T, Kalinin S, Tanç M, Supuran CT. Krasavin M, et al. Among authors: korsakov m. J Enzyme Inhib Med Chem. 2017 Dec;32(1):920-934. doi: 10.1080/14756366.2017.1344236. J Enzyme Inhib Med Chem. 2017. PMID: 28718328 Free PMC article.

5

1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads.

Ferraroni M, Lucarini L, Masini E, Korsakov M, Scozzafava A, Supuran CT, Krasavin M. Ferraroni M, et al. Among authors: korsakov m. Bioorg Med Chem. 2017 Sep 1;25(17):4560-4565. doi: 10.1016/j.bmc.2017.06.054. Epub 2017 Jul 11. Bioorg Med Chem. 2017. PMID: 28728897

6

Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.

Krasavin M, Shetnev A, Baykov S, Kalinin S, Nocentini A, Sharoyko V, Poli G, Tuccinardi T, Korsakov M, Tennikova TB, Supuran CT. Krasavin M, et al. Among authors: korsakov m. Eur J Med Chem. 2019 Apr 15;168:301-314. doi: 10.1016/j.ejmech.2019.02.044. Epub 2019 Feb 15. Eur J Med Chem. 2019. PMID: 30826507

7

Investigation of pyrazolo[1,5-a]quinoxalin-4-ones as novel monoamine oxidase inhibitors.

Panova VA, Filimonov SI, Chirkova ZV, Kabanova MV, Shetnev AA, Korsakov MK, Petzer A, Petzer JP, Suponitsky KY. Panova VA, et al. Among authors: korsakov mk. Bioorg Chem. 2021 Mar;108:104563. doi: 10.1016/j.bioorg.2020.104563. Epub 2020 Dec 15. Bioorg Chem. 2021. PMID: 33376014

8

Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile.

Sharonova T, Zhmurov P, Kalinin S, Nocentini A, Angeli A, Ferraroni M, Korsakov M, Supuran CT, Krasavin M. Sharonova T, et al. Among authors: korsakov m. J Enzyme Inhib Med Chem. 2022 Dec;37(1):857-865. doi: 10.1080/14756366.2022.2051023. J Enzyme Inhib Med Chem. 2022. PMID: 35296197 Free PMC article.

9

5-(Sulfamoyl)thien-2-yl 1,3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery.

Kalinin S, Kovalenko A, Valtari A, Nocentini A, Gureev M, Urtti A, Korsakov M, Supuran CT, Krasavin M. Kalinin S, et al. Among authors: korsakov m. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1005-1011. doi: 10.1080/14756366.2022.2056733. J Enzyme Inhib Med Chem. 2022. PMID: 35350949 Free PMC article.

10

A Series of Trifluoromethylisoxazolyl- and Trifluoromethylpyrazolyl- Substituted (Hetero)aromatic Sulfonamide Carbonic Anhydrase Inhibitors: Synthesis, and Convenient Prioritization Workflow for Further In Vivo Studies.

Sibinčić N, Kalinin S, Sharoyko V, Efimova J, Gasilina OA, Korsakov M, Gureev M, Krasavin M. Sibinčić N, et al. Among authors: korsakov m. Med Chem. 2023;19(2):193-210. doi: 10.2174/1573406418666220831112049. Med Chem. 2023. PMID: 36045518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters